drugset / Trial / NCT01832870
Sipuleucel-T and Ipilimumab for Advanced Prostate Cancer
NaSingle-groupOpen-labelTreatment
Summary
This is a clinical trial designed to quantify the immune response and determine the tolerability and side effects of sipuleucel-T when given in combination with ipilimumab for patients with advanced prostate cancer.
Timeline
- Start
- 2013-04
- Primary completion
- 2016-02
- Completion
- 2016-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sipuleucel-T | Cell therapy | — | — |
| Background | Ipilimumab | Monoclonal antibody | — | — |